Spinifex Pharma

Spinifex Pharmaceuticals is a clinical-stage Australian biotechnology company specialising in the development of products for the treatment of pain.

News & Events

23RD DECEMBER 2011

Spinifex set to present at the Biotech Showcase 2012 conference in San Francisco
Read More

6TH DECEMBER 2011

Appointment of Spinifex Non-Executive Chairman.
Read More

16TH NOVEMBER 2011

Pharma Television interviewed Tom McCarthy, Spinifex CEO, at the Bio-Partnering Europe conference held in London in October 2011.
Read More

1ST NOVEMBER 2011

Spinifex Pharmaceuticals Presented at the BioPartnering Europe, BIO Investor Forum and BIO-Europe Conferences in Late 2011.
Read More

19TH SEPTEMBER 2011

Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Postherpetic Neuralgia
Read More

12TH SEPTEMBER 2011

New Data on EMA401 in Model of Diabetic Neuropathy Presented at the 21st Annual NEURODIAB Meeting
Read More

29TH AUGUST 2011

Spinifex Pharmaceuticals featuring in BioCentury, The Bernstein Report on BioBusiness
Read More

23RD AUGUST 2011

Spinifex Closes AU$18.25M (~US$19M) Expanded Series B Round to Broaden Phase 2 Program
Read More

14TH APRIL 2011

Spinifex Pharmaceuticals featuring in the AusIndustry Innovation Australia Showcase in April 2011
Read More

Latest News & Events

23RD DECEMBER 2011 Spinifex set to present at the Biotech Showcase 2012 conference in San Francisco ... More

6TH DECEMBER 2011 Appointment of Spinifex Non-Executive Chairman. ... More

19TH SEPTEMBER 2011 Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Postherpetic Neuralgia ... More